UPDATED: FDA Issues Approval for Noodle Product Banned by Indian Government
The U.S. Food and Drug Administration (FDA) has weighed in on the dispute between Nestle and the Indian government.
Over the weekend, the FDA conducted an analysis of a sample of Nestle's Maggi noodles, determining that the product is safe for consumption, according to The Economic Times. The Food Safety and Standards Authority of India (FSSAI) decided to ban the sale of Maggi noodles in the country on June 5, 2015, based on allegations of high levels of lead and mislabeling on packs which declared 'no added MSG'.
The Swiss multinational food and beverage company has maintained that its product's lead levels fall within acceptable standards and that any test revealing high levels of MSG are simply a result of high natural glutamate, a substance found in hydrolyzed groundnut protein, onion powder and wheat flour.
The FDA is the seventh national food regulator to approve Maggi noodles. Similar agencies in the UK, Singapore, Canada, Australia, New Zealand, and Vietnam have given the product a clean bill of health.
The controversy over Maggi noodles in India have been ongoing since March 2014, when the product failed a routine test in the Uttar Pradesh city of Barabanki.
Update: According to Bloomberg News, a two-judge panel of the Bombay High Court found the FSSAI order to be arbitrary, which allows Nestle to resuming selling the product. Nestle will be required to submit an updated labratory analysis within six weeks.